Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies.
Journal Information
Full Title: Cardiovasc Diabetol
Abbreviation: Cardiovasc Diabetol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing interestsThe authors declare no competing interests. Ethics approval and consent to participateNot applicable. Consent for publicationAll authors have read and approved the manuscript. Competing interests The authors declare no competing interests."
"Funding Not applicable."
"This meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The protocol has been published in the PROSPERO International prospective register of systematic reviews (CRD42023264057). Using the search algorithm detailed in the Supplementary Material Data file, four electronic databases [PUBMED, Web Of Science (WOS), Cochrane Central Register of Controlled Trials, OVID MEDLINE] were searched for RCTs published until June 2022 without any restriction regarding study duration and sample size. Reference lists of all identified studies were also manually searched for further relevant investigations. Reviews, meta-analyses, case reports, summary articles, letters without data, conference abstracts, editorials, posters, nonhuman studies, and non-English articles were excluded."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025